Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE-ε4

Guen, Yann Le, Belloy, Michael E, Grenier-Boley, Benjamin, de Rojas, Itziar, Castillo, Atahualpa, Jansen, Iris E, Nicolas, Aude, Bellenguez, Céline, Dalmasso, Carolina, Küçükali, Fahri, Eger, Sarah J, Álvarez-Martínez, Victoria, Arosio, Beatrice, Benussi, Luisa, Boland, Anne, Borroni, Barbara, Bullido, María J., Caffarra, Paolo, Clarimón, Jordi, Daian, Delphine, Daniele, Antonio, Debette, Stéphanie, Deleuze, Jean?François, Dichgans, Martin, Dufouil, Carole, Duzel, Emrah, Galimberti, Daniela, García-Alberca, Jose María, García-González, Pablo, Giedraitis, Vilmantas, Grimmer, Timo, Graff, Caroline, Grunblatt, Edna, Hanon, Olivier, Hausner, Lucrezia, Heilmann-Heimbach, Stefanie, Holstege, Henne, Hort, Jakub, Jurgen, Deckert, Kuulasmaa, Teemu, van der Lugt, Aad, Masullo, Carlo, Mecocci, Patrizia, Mehrabian, Shima, de Mendonça, Alexandre, Boada, Mercè, Mir, Pablo, Moebus, Susanne, Moreno, Fermin, Nacmias, Benedetta, Nicolas, Gaël, Papenberg, Goran, Parnetti, Lucilla, Pasquier, Florence, Pastor, Pau, Peters, Oliver, Pijnenburg, Yolande A.L., Piñol-Ripoll, Gerard, Popp, Julius, Molina, Laura, Puerta, Raquel, Pérez-Tur, Jordi, Rainero, Innocenzo, Ramakers, Inez H.G.B., Rasmussen, Katrine Laura, Real, Luis Miguel, Riedel-Heller, Steffi G., Rodríguez, Eloy Rodríguez, Royo, José Luís, Rujescu, Dan, Scarmeas, Nikolaos, Scheltens, Philip, Scherbaum, Norbert, Schneider, Anja, Seripa, Davide, Soininen, Hilkka, Solfrizzi, Vincenzo, Spalletta, Gianfranco, Squassina, Alessio, van Swieten, John C, Sanchez-Valle, Raquel, Tegos, Thomas, Thomassen, Jesper Qvist, Tremolizzo, Lucio, Verhey, Frans R.J., Vyhnalek, Martin, Wiltfang, Jens, He, Zihuai, Napolioni, Valerio, Amouyel, Philippe, Jessen, Frank, Kehoe, Patrick G, van Duijn, Cornelia M, Tsolaki, Magda, Sanchez-Juan, Pascual, Sleegers, Kristel, Ingelsson, Martin, Rossi, Giacomina, Hiltunen, Mikko, Sims, Rebecca ORCID: https://orcid.org/0000-0002-3885-1199, van der Flier, Wiesje M., Ramirez, Alfredo, Andreassen, Ole, Frikke-Schmidt, Ruth, Williams, Julie ORCID: https://orcid.org/0000-0002-4069-0259, Ruiz, Agustin, Lambert, Jean-Charles and Greicius, Michael D 2022. Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE-ε4. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 18 (S4) , e060114. 10.1002/alz.060114

Preview

PDF - Accepted Post-Print Version Download (631kB) | Preview

Abstract

Background Despite decades of research, the mechanisms linking APOE to Alzheimer’s disease (AD) remain poorly understood. Finding additional risk variants at the APOE locus, beyond the common APOE-ε2 and APOE-ε4 alleles, may help elucidate how APOE is involved in the disease. Method Association with case-control status was tested in a sequenced discovery sample (Stage 1) and followed-up in several microarray imputed cohorts as well as the UK Biobank whole-exome sequencing resource using a proxy-AD phenotype (Stages 2+3) (Table 1). Stage 1 included 37,409 non-unique participants of European or Admixed-European ancestry, with 11,868 cases and 11,934 controls passing analysis inclusion criteria. In Stages 2+3, 475,473 participants were considered across 8 cohorts, of which 56,029 cases, 28,484 proxy-AD cases, and 328,372 healthy-controls passed inclusion criteria, and were of European ancestry. Result Two missense variants were associated with a two to three-fold decreased AD risk: R251G (odds ratio, 0.44; 95% confidence interval [CI], 0.33-0.59; P = 4.7×10-8) and V236E (odds ratio, 0.37; 95% CI, 0.25-0.56; P = 1.9×10-6) (Table 2, Figures 1, 2). Additionally, the cumulative incidence of AD in carriers of these variants was found to grow more slowly with age compared to non-carriers (Table 3). Conclusion We identified a novel variant associated with AD, R251G, which mitigates the ε4 associated AD risk, and confirmed the protective effect of the V236E variant. The location of the variants confirms that the carboxyl-terminal portion of apoE plays an important role in AD pathogenesis. The large risk reductions reported here, suggest that protein chemistry and functional assays of these variants have the potential to identify novel pathways for drug development.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Advanced Research Computing @ Cardiff (ARCCA) MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine
Publisher:	Wiley
ISSN:	1552-5260
Date of First Compliant Deposit:	13 February 2023
Date of Acceptance:	20 December 2022
Last Modified:	07 Nov 2024 10:00
URI:	https://orca.cardiff.ac.uk/id/eprint/156929

Actions (repository staff only)

Edit Item